Getinge AB ser. B (GETIBs)

Currency in SEK
220.80
+1.40(+0.64%)
Closed·
GETIBs is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
220.80220.80
52 wk Range
167.07225.60
Key Statistics
Bid/Ask
186.20 / 187.65
Prev. Close
220.8
Open
220.8
Day's Range
220.8-220.8
52 wk Range
167.07-225.6
Volume
514
Average Volume (3m)
1.54K
1-Year Change
18.71%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GETIBs Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory

Getinge AB ser. B News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Strong Buy

Getinge AB ser. B Company Profile

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It provides extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage solutions. In addition, the company offers surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, vascular and cardiothoracic surgery equipment, peripheral stenting, OEM solutions, and beating heart surgery equipment; and operating room equipment, anesthesia, advanced patient monitoring, and operating room integration solutions. Further, it provides pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices, and patient flow management; and low temperature sterilization, biocontainment in vaccine production, terminal sterilization, sterile isolation technology, cleaning and sterilization, aseptic transfer, and large-scale cultivation. Additionally, the company provides bioreactor preparation solution, bioprocess development and optimization, labware cleaning and sterilization, biocontainment, and vivarium. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.

Employees
11794
Market
Sweden

Compare GETIBs to Peers and Sector

Metrics to compare
GETIBs
Peers
Sector
Relationship
P/E Ratio
28.5x26.4x−0.6x
PEG Ratio
1.330.210.00
Price/Book
2.0x2.6x2.6x
Price / LTM Sales
1.6x3.3x3.3x
Upside (Analyst Target)
-0.0%41.7%
Fair Value Upside
Unlock20.0%5.1%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 7.54%
Dividend Yield
2.08%
Industry Median 2.09%
Annualised payout
4.60
Paid annually
5-Years Growth
+25.12%
Growth Streak

Earnings

Latest Release
Oct 21, 2025
EPS / Forecast
2.42 / 2.16
Revenue / Forecast
8.23B / 8.03B
EPS Revisions
Last 90 days

GETIBs Income Statement

People Also Watch

311.1
NOVOb
-2.39%
9.004
STLAM
-2.60%
133.50
CAPP
-0.85%
5.7400
CPRI
-1.24%
430.00
BOL
-1.08%

FAQ

What Stock Exchange Does Getinge B Trade On?

Getinge B is listed and trades on the BATS Europe stock exchange.

What Is the Stock Symbol for Getinge B?

The stock symbol for Getinge B is "GETIBs."

What Is the Getinge B (GETIBs) Afterhours Price Today? (Afterhours variable test: 0.00) Current Date: 16 Nov 2025

After hours price: 0.00. After hours price change (units): 0.00. Price change percentage: 0.00%

What Is the Getinge B Market Cap?

As of today, Getinge B market cap is 58.64B.

What Is Getinge B's Earnings Per Share (TTM)?

The Getinge B EPS (TTM) is 7.54.

When Is the Next Getinge B Earnings Date?

Getinge B will release its next earnings report on 03 Feb 2026.

From a Technical Analysis Perspective, Is GETIBs a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Getinge B Stock Split?

Getinge B has split 3 times.

How Many Employees Does Getinge B Have?

Getinge B has 11794 employees.

What is the current trading status of Getinge B (GETIBs)?

As of 16 Nov 2025, Getinge B (GETIBs) is trading at a price of 220.80, with a previous close of 220.80. The stock has fluctuated within a day range of 220.80 to 220.80, while its 52-week range spans from 167.07 to 225.60.

What Is the GETIBs After Hours Price?

GETIBs's last after hours stock price is 0.00, the stock has decreased by 0.00, or 0.00%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.